CSIR-IIIM Jammu, developed a prototype Novel drug delivery formulation (Gastro Retentive sustained release) on the standardised extract and has been granted a patent, bearing CSIR Granted No. 0120NF2017/IN. CSIR-IIIM Jammu also filled international patent for the same drug delivery formulation.
The present invention comprising an effective amount of an extract or lyophilized extract at least one bioactive fraction obtained from IIIM 160 A002 (Bergenia ciliata) along with one or more pharmaceutically acceptable additives/carriers. This invention envisages the potential of an extract obtained from the whole plant of IIIM 160 A002 (Bergenia ciliata) to act an effective therapy against Anti-inflammatory & rheumatoid arthritis.
With this background data, CSIR-IIIM, Jammu has to be compiling a dossier (IND) to the AYUSH department to conduct the Phase-I Clinical trial on Healthy volunteer through CRO.